We’re building a massive library of biosensor assays so we can immediately tailor our analysis platform to your needs while maintaining accuracy.
You design the experiments,
we deliver the data. You name the target or pathway, we provide appropriate screening and assessments.
Our reliable, reproducible data will provide you with the information to assess the toxicity, effects, and viability of your drug prior to phase I clinical testing.
Using Fluorescent genes derived from Aequorea Victoria, we engineer proteins and cells to sense drug effects with imaging technology.
We’re applying AI to a library of specific biosensors to automate preclinical drug trials.
Our Förster Resonance Energy Transfer (FRET) biosensors are pathway-specific, enabling you to customize our experiments based on your compounds.